Sipp Industries Forges Distribution Agreement with SinuSave®'s CBD Nasal Spray

Published on: 

Sipp Industries, Inc., reaches a distribution agreement with SinuSave® regarding their SinuSave® CBD Nasal Spray products.

A recent press release disclosed that Sipp Industries, Inc., (Sipp Industries) has reached a distribution agreement with SinuSave® (1). This deal is in regard to SinuSave®’s patented cannabidiol (CBD) Nasal Spray products which are offered in two dosages, 500mg and 1000mg and is “bacteriostatic” and “bactericidal” (1). Additionally, the CBD nasal spray is formulated with a patented mixture of nine essential oils.

The cannabinoid, CBD, has become well-known to cannabis users for its pain relieving properties. The press release mentions that this cannabinoid might also be of help in relieving allergy, sinusitis, air pollution, and cold symptoms (1). Pertaining to daily nasal hygiene, the CBD nasal spray, is currently the only patented drug-free product created for this purpose.

“This partnership with SinuSave® represents an exciting leap forward for SIPP Industries,” Jakob Jorgensen, CEO of SIPP Industries, mentioned (1). “We are incredibly proud to align ourselves with a product that has the potential to transform the well-being of individuals seeking advanced, effective solutions for nasal health. The patent-pending, nano-emulsified CBD technology showcased in SinuSave's nasal spray is a game-changer, and we are thrilled to be at the forefront of its distribution.”


The Original SinuSave® nasal spray has been around since 2017 (1). Their new CBD product provides similar benefits with the addition of the medical properties the cannabinoid provides.

“The SinuSave® CBD Nasal Spray is set to revolutionize how individuals approach nasal health. With our distribution agreement with SIPP Industries, we are excited to reach more consumers and make a positive impact on their well-being,” Lou Lobel, President of SinuSave®, explained (1). “This strategic partnership is poised to empower consumers seeking alternative, natural solutions for nasal care. It showcases a shared commitment to innovation, quality, and excellence in the wellness landscape.”

According to Sipp Industries press release (1), the global nasal market was previously valued at $24.5 billion in 2022. Data from Verified Market Research foresees these numbers to increase at a compound annual growth rate (CAGR) of 6.7% (1).

Per the distribution agreement, Sipp Industries will be in charge of the distribution, sales,and marketing of SinuSave®’s CBD nasal spray products (1). The items from SinuSave®’s product lineup will be offered in retail stores and online soon. Sipp Industries is also investigating distributing SinuSave®’s products internationally as well.


  1. Sipp Industries, Inc. Sipp Industries Announces Distribution Agreement for Patented SinuSave® CBD Nasal Spray (accessed Jan 23, 2024).